Europe Biodefense Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Biodefense Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Biodefense Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Biodefense Market Regional Analysis

6.2 Europe Biodefense Market Revenue 2017-2027 (US$ Million)

6.3 Europe Biodefense Market Forecast Analysis

7. Europe Biodefense Market Analysis – by Product

7.1 Anthrax

7.1.1 Overview
7.1.2 Anthrax: Europe Biodefense Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Small pox

7.2.1 Overview
7.2.2 Small pox: Europe Biodefense Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Botulism

7.3.1 Overview
7.3.2 Botulism: Europe Biodefense Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Radiation/Nuclear

7.4.1 Overview
7.4.2 Radiation/Nuclear: Europe Biodefense Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Biodefense Market – Europe Analysis

8.1 Overview

8.2 Europe

8.2.1 Europe Biodefense Market Breakdown, by Key Country, 2020 and 2027 (%)
8.2.1.1 Europe Biodefense Market – Revenue and Forecast Analysis – by Country
8.2.1.1 UK: Europe Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.1.1 UK: Europe Biodefense Market Breakdown, by Product

8.2.1.2 Germany: Europe Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.2.1 Germany: Europe Biodefense Market Breakdown, by Product

8.2.1.3 France: Europe Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.3.1 France: Europe Biodefense Market Breakdown, by Product

8.2.1.4 Russia: Europe Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.4.1 Russia: Europe Biodefense Market Breakdown, by Product

8.2.1.5 Italy: Europe Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.5.1 Italy: Europe Biodefense Market Breakdown, by Product

8.2.1.6 Rest of Europe: Europe Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.6.1 Rest of Europe: Europe Biodefense Market Breakdown, by Product

9. Competitive Landscape

9.1 Heat Map Analysis

9.2 Company Positioning and Concentration

10. Industry Landscape

10.1 Overview

10.2 Market Initiative

10.3 Partnerships and Collaborations

10.4 Other Developments

11. Company Profiles

11.1 Bavarian Nordic

11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments

11.2 Alnylam Pharmaceuticals, Inc.

11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments

11.3 SIGA Technologies

11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments

11.4 Emergent BioSolutions Inc.

11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

11.5 Cleveland Bio Labs

11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

11.6 Dynavax Technologies

11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments

11.7 Elusys Therapeutics, Inc.

11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

11.8 Soligenix

11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments

11.9 Altimmune

11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

11.10 Pluristem Therapeutics

11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix

12.1 About Business Market Insights

12.2 List of Abbreviations

Europe Biodefense Market

Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography